Global Multiple Sclerosis Drugs Market 2014-2018 New Research Report
The report Global Multiple Sclerosis Drugs Market 2014-2018 says one of the emerging trends in the market is the introduction of disease-modifying drugs as a treatment option. Drugs such as Copaxone (Glatiramer Acetate) by Teva Pharmaceuticals and Tysabri (Natalizumab) by Biogen Idec are increasingly used in the treatment of multiple sclerosis.
View full press release